Přehled o publikaci
2022
No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers
RADVAN, Martin; Martin KAMENÍK; Lumír KOC; Gabriela MATEJOVÁ; Eliška BARTEČKOVÁ et al.Basic information
Original name
No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers
Authors
RADVAN, Martin; Martin KAMENÍK; Lumír KOC; Gabriela MATEJOVÁ; Eliška BARTEČKOVÁ; Jana HOŘÍNKOVÁ; Radka ŠTĚPÁNOVÁ and Petr KALA
Edition
ESC Congress 2022 - Barcelona, Spain 26–29 August 2022, 2022
Other information
Type of outcome
Konferenční abstrakta
Confidentiality degree
is not subject to a state or trade secret
References:
Marked to be transferred to RIV
No
Organization
Lékařská fakulta – Repository – Repository
Links
LX22NPO5107, research and development project.
Changed: 17/1/2023 03:52, RNDr. Daniel Jakubík
Abstract
In the original language
lt;0.001) between V1 a V3, a mild enlargement of left atrium (37.1±5.85 to 38.2±5.65mm; p=0,021) and nonsignificant trend to impairment of left ventricle diastolic dysfunction. There was a mild change of pulmonary artery systolic pressure (24.7±7.92 to 27.5±6.97mmHg; p=0,038). Conclusion: Despite many information regarding cardiac impairment of SARS-CoV-2 our study does not suggest increased risk of development of heart failure during the one year follow-up. Based on our results the routine echocardiography and biomarkers collection is currently not recommended after COVID-19 recovery.
